Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2025-03-28 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
监事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 14th meeting of the 6th Supervisory Board of Yingkang Life Technology Co., Ltd. It includes approvals of various reports related to the 2024 fiscal year such as the Supervisory Board Work Report, General Manager Work Report, Annual Report, Financial Statements, Internal Control Evaluation Report, Fundraising Use Report, Profit Distribution Plan, and others. The document also mentions that these reports are disclosed separately on the official information disclosure platform (巨潮资讯网) and will be submitted to the 2024 Annual General Meeting for approval. The document itself is a meeting resolution announcement rather than the full annual report or financial statements. It contains substantive content about the supervisory board's review and approval of the annual reports and financial results but does not contain the full financial statements or detailed financial data itself. Given the nature of the document as a Supervisory Board meeting resolution announcement covering the review and approval of the annual report and related financial documents, it fits best under the category of Board/Management Information (MANG). The document is over 5,000 characters and contains detailed meeting content, so it is not a simple report publication announcement or regulatory filing. Therefore, the classification is MANG with high confidence.
2025-03-28 Chinese
关于召开2024年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2024 Annual General Meeting (AGM) of 盈康生命科技股份有限公司, including the date, time, location, voting procedures, agenda items, and proxy forms. It does not contain the actual annual report, financial statements, or results but rather the announcement and procedural information for the AGM. The document length is about 4982 characters, which is consistent with a detailed meeting notice rather than a full report. The content focuses on the meeting logistics and agenda proposals to be voted on, which aligns with the definition of AGM Information (AGM-R).
2025-03-28 Chinese
国泰君安证券股份有限公司关于盈康生命科技股份有限公司重大资产购买暨关联交易之2024年度业绩承诺实现情况及业绩承诺期届满减值测试情况的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a specialized verification opinion from an independent financial advisor (Guotai Junan Securities Co., Ltd.) regarding the performance commitment realization and impairment test at the end of the commitment period for a major asset purchase and related party transaction involving Yingkang Life Technology Co., Ltd. It includes detailed financial data on performance commitments, compensation mechanisms, and impairment testing results, supported by audit and asset appraisal reports. The document is not a full annual report or interim report but a standalone audit-related verification report focused on a specific transaction and its financial implications. It is not a mere announcement or certification but contains substantive financial analysis and conclusions. Therefore, it fits the category of an Audit Report / Information (AR). The document length (2864 characters) and content confirm it is a detailed audit-related report rather than a brief announcement or certification. FY 2024
2025-03-28 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the sixteenth meeting of the sixth board of directors of 盈康生命科技股份有限公司. It includes approvals of the 2024 annual board work report, general manager's report, the full 2024 annual report and its summary, the 2024 financial statements audited by an accounting firm, internal control evaluation report, independent directors' independence report, fundraising usage report, sustainable development report, profit distribution plan, reappointment of the accounting firm, credit line application, remuneration plans for directors and senior management, performance commitment reports, impairment test reports, and other related matters. The document repeatedly references the 2024 annual report and related reports being disclosed on the official information disclosure website (巨潮资讯网) and states that these reports will be submitted to the 2024 annual shareholders meeting for approval. The document is comprehensive, over 8,700 characters, and contains substantive content about the company's financial and governance matters, but it is not the annual report itself. Instead, it is a board meeting resolution announcement summarizing the board's decisions and approvals regarding the annual report and other related reports. This type of document fits best under the category of Board/Management Information (MANG), as it announces board meeting resolutions and management reports rather than being the full annual report or audit report itself.
2025-03-28 Chinese
董事会审计委员会关于对会计师事务所2024年度履职情况评估及履行监督职责情况的报告
Audit Report / Information Classification · 95% confidence The document is a detailed report from the Board Audit Committee regarding the supervision of the accounting firm for the 2024 fiscal year. It discusses the qualifications, audit procedures, quality management, and oversight activities related to the external auditor's work on the company's 2024 annual financial report and internal control audit. The content focuses on audit supervision and the audit firm's performance rather than presenting the full annual financial statements or the complete annual report. This matches the description of an Audit Report / Information (AR), which includes standalone audit reports and results of internal or regulatory audits, excluding the full Annual Report (10-K). The document length is 3562 characters, which is sufficient for a detailed audit report but not a full annual report. There is no indication that this is a mere announcement or certification, so it is not RPA or RNS. Therefore, the correct classification is AR with high confidence. FY 2024
2025-03-28 Chinese
国泰君安证券股份有限公司关于盈康生命科技股份有限公司2024年度持续督导跟踪报告
Regulatory Filings Classification · 95% confidence The document is titled as a "2024年度持续督导跟踪报告" (2024 Annual Continuous Supervision Follow-up Report) issued by a sponsoring institution (国泰君安证券股份有限公司) regarding a company (盈康生命科技股份有限公司). It details the sponsor's review and supervision activities, including information disclosure, internal controls, fundraising supervision, governance, and compliance with regulatory requirements. The document includes tables summarizing work content, findings, and measures taken, as well as company and shareholder commitments. It is not a full annual report or financial statement but a regulatory supervision follow-up report. The document length is 2154 characters, which is relatively short and focused on supervision activities rather than financial results or management discussion. This type of document fits best under Regulatory Filings (RNS), as it is a compliance and supervisory report rather than a financial report or announcement of voting results, management changes, or capital updates.
2025-03-28 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.